MA13.02 Phase II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Recurrent Non-Small Cell Lung Cancer

Autor: Puri, S., Tanvetyanon, T., Creelan, B., Shafique, M., Saltos, A., Chiappori, A., Haura, E., Thapa, R., Chen, D., Antonia, S., Gray, J.
Zdroj: In Journal of Thoracic Oncology October 2021 16(10) Supplement:S924-S925
Databáze: ScienceDirect